These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 15340327)
1. [Insulin therapy in patients with myocardial ischemia and type II diabetes before and after myocardial revascularization]. Mashkova OV; Belov IuV; Ametov AS; Kalina NV Khirurgiia (Mosk); 2004; (7):36-7. PubMed ID: 15340327 [TBL] [Abstract][Full Text] [Related]
2. [Results of surgical treatment of coronary heart disease in patients with type II diabetes mellitus]. Mashkova OV; Belov IuV; Ametov AS; Kalina NV Khirurgiia (Mosk); 2004; (6):34-5. PubMed ID: 15211337 [TBL] [Abstract][Full Text] [Related]
3. Patients with diabetes mellitus undergoing cardiac surgery are at greater risk for developing intraoperative myocardial acidosis. Kumbhani DJ; Healey NA; Thatte HS; Nawas S; Crittenden MD; Birjiniuk V; Treanor PR; Khuri SF J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1566-72. PubMed ID: 17532958 [TBL] [Abstract][Full Text] [Related]
5. Cardiopulmonary bypass increases postoperative glycemia and insulin consumption after coronary surgery. Knapik P; Nadziakiewicz P; Urbanska E; Saucha W; Herdynska M; Zembala M Ann Thorac Surg; 2009 Jun; 87(6):1859-65. PubMed ID: 19463610 [TBL] [Abstract][Full Text] [Related]
6. [Diabetes mellitus in coronary bypass surgery: risks and chances. Treatment concepts for a particularly challenging group of patients]. Lauruschkat AH; Ennker J Herz; 2008 Apr; 33(3):212-21. PubMed ID: 18568316 [TBL] [Abstract][Full Text] [Related]
7. [The results of endovascular and surgical myocardial revascularization in patients with type II diabetes mellitus]. Arablinskiĭ AV; Ovesian ZR; Kulikov AV; Shanoian AS Klin Med (Mosk); 2005; 83(5):14-8. PubMed ID: 15984575 [No Abstract] [Full Text] [Related]
8. Impact of treatment of coronary artery disease with sirolimus-eluting stents on outcomes of diabetic and nondiabetic patients. Kuchulakanti PK; Torguson R; Canos D; Rha SW; Chu WW; Clavijo L; Deible R; Gevorkian N; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R Am J Cardiol; 2005 Oct; 96(8):1100-6. PubMed ID: 16214445 [TBL] [Abstract][Full Text] [Related]
9. Outcome of coronary revascularisation in diabetes. Smits P Neth J Med; 2006 Sep; 64(8):265-6. PubMed ID: 16990688 [No Abstract] [Full Text] [Related]
10. [Long-term results of coronary endovascular revascularisation with sirolimus-eluting stents in patients with ischemic heart disease comorbid with type-2 diabetes mellitus: data from 18-month prospective study]. Tepliakov AT; Torim IuIu; Kuznetsova AV; Rybal'chenko EV; Krylov AL; Karpov RS Ter Arkh; 2009; 81(5):54-60. PubMed ID: 19537588 [TBL] [Abstract][Full Text] [Related]
11. Direct costs and health-related resource utilisation in the 6 months after insulin initiation in German patients with type 2 diabetes mellitus in 2006: INSTIGATE study. Liebl A; Breitscheidel L; Nicolay C; Happich M Curr Med Res Opin; 2008 Aug; 24(8):2349-58. PubMed ID: 18606055 [TBL] [Abstract][Full Text] [Related]
12. Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model. Patriti A; Facchiano E; Annetti C; Aisa MC; Galli F; Fanelli C; Donini A Obes Surg; 2005 Oct; 15(9):1258-64. PubMed ID: 16259883 [TBL] [Abstract][Full Text] [Related]
13. Revascularization trumps medicine for patients with type 2 diabetes mellitus and chronic angina (or does it?). Marso SP Circulation; 2011 Apr; 123(14):1489-91. PubMed ID: 21444884 [No Abstract] [Full Text] [Related]
14. QT-interval dispersion in type 2 diabetic and non-diabetic patients with post-myocardial infarction. Sakabe K; Fukuda N; Fukuda Y; Wakayama K; Nada T; Morishita S; Shinohara H; Tamura Y Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):121-6. PubMed ID: 17346952 [TBL] [Abstract][Full Text] [Related]
15. [The FIELD study presented and published. Unconvincing results of fenofibrates in diabetic patients]. Widimský J Vnitr Lek; 2006 Jan; 52(1):80-4. PubMed ID: 16526203 [TBL] [Abstract][Full Text] [Related]
16. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial. Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW; J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986 [TBL] [Abstract][Full Text] [Related]
17. [The use of infrared laser radiation in the rehabilitation of IHD patients after the surgical revascularization of the myocardium]. Kniazeva TA; Nagapet'ian VK Vopr Kurortol Fizioter Lech Fiz Kult; 1994; (6):10-2. PubMed ID: 7762198 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN). Knopp RH; d'Emden M; Smilde JG; Pocock SJ Diabetes Care; 2006 Jul; 29(7):1478-85. PubMed ID: 16801565 [TBL] [Abstract][Full Text] [Related]
19. Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease. Marazzi G; Wajngarten M; Vitale C; Patrizi R; Pelliccia F; Gebara O; Pierri H; Ramires JA; Volterrani M; Fini M; Rosano GM Int J Cardiol; 2007 Aug; 120(1):79-84. PubMed ID: 17134770 [TBL] [Abstract][Full Text] [Related]